The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Aim
To assess the effectiveness and safety of rivaroxaban vs warfarin in people with non‐valvular atrial fibrillation and diabetes treated in routine practice.
Methods
Using US MarketScan claims data for the period November 2011 to December 2016, we identified oral anticoagulation‐naïve people with non‐valvular atrial fibrillation and diabetes (Type 1 or Type 2) and ≥12 months of continuous insurance...
ObjectiveTo validate the In‐hospital Mortality for PulmonAry embolism using Claims daTa (IMPACT) multivariable prediction rule using admission claims data.
Study designRetrospective claims database analysis.
MethodsThis analysis was performed using Humana admission claims data from January 2007 to March 2014. We included adult patients admitted for their first PE during this period (International...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.